PubMed:19880293 / 2226-2359 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T20","span":{"begin":0,"end":133},"obj":"Sentence"}],"text":"Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36)."}

{"project":"LitCoin-entities","denotations":[{"id":"6703","span":{"begin":15,"end":20},"obj":"GeneOrGeneProduct"},{"id":"6704","span":{"begin":21,"end":35},"obj":"SequenceVariant"},{"id":"6705","span":{"begin":77,"end":86},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6706","span":{"begin":87,"end":95},"obj":"OrganismTaxon"}],"attributes":[{"id":"A44","pred":"db_id","subj":"6703","obj":"NCBIGene:50943"},{"id":"A45","pred":"db_id","subj":"6704","obj":"c|Allele|GA|IVS9+459"},{"id":"A46","pred":"db_id","subj":"6705","obj":"MESH:D011565"},{"id":"A47","pred":"db_id","subj":"6706","obj":"NCBITaxon:9606"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36)."}

{"project":"LitCoin_Mondo","denotations":[{"id":"T11","span":{"begin":77,"end":86},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"0005083"}],"text":"Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36)."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T41","span":{"begin":15,"end":20},"obj":"GeneOrGeneProduct"},{"id":"T42","span":{"begin":77,"end":86},"obj":"GeneOrGeneProduct"}],"text":"Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36)."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T27","span":{"begin":15,"end":20},"obj":"GeneOrGeneProduct"},{"id":"T28","span":{"begin":77,"end":86},"obj":"GeneOrGeneProduct"}],"text":"Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36)."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T11","span":{"begin":77,"end":86},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A11","pred":"originalLabel","subj":"T11","obj":"D011565"}],"text":"Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36)."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T15","span":{"begin":15,"end":20},"obj":"GeneOrGeneProduct"}],"text":"Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36)."}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T13","span":{"begin":77,"end":86},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A13","pred":"mondo_id","subj":"T13","obj":"0005083"}],"text":"Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36)."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T15","span":{"begin":77,"end":86},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A15","pred":"ID:","subj":"T15","obj":"D011565"}],"text":"Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36)."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T15","span":{"begin":77,"end":86},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A15","pred":"#label","subj":"T15","obj":"D011565"}],"text":"Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36)."}

{"project":"LitCoin-NCBITaxon-2","denotations":[{"id":"T6","span":{"begin":87,"end":95},"obj":"OrganismTaxon"}],"text":"Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36)."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T15","span":{"begin":15,"end":20},"obj":"GeneOrGeneProduct"},{"id":"T48189","span":{"begin":77,"end":86},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T61850","span":{"begin":87,"end":95},"obj":"OrganismTaxon"}],"attributes":[{"id":"A15","pred":"#label","subj":"T48189","obj":"D011565"}],"text":"Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36)."}